August 23, 2021
Andrea Park
Delfi Diagnostics’ AI-based blood test detects 80% of early stage lung cancer cases, study finds
Delfi Diagnostics’ liquid biopsy test uses machine learning to spot changes in patients’ DNA fragmentation profiles that indicate the presence of cancerous cells.
